The Therapeutic Potential of Targeting the Chd Protein Family in Cancer
Year: 2023
Type: review
Source: Pharmacology & Therapeutics
Authors: Min Zhang, Kaiyuan Wu, Weijie Zhang, Xia Lin, Qi Cao, Lili Zhang, Kaifu Chen
Institutions: First Affiliated Hospital Zhejiang University, Zhejiang University, Boston Children's Hospital, Harvard University, Rice University, Second Affiliated Hospital of Zhejiang University, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Dana-Farber/Harvard Cancer Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Awards: Computational epigenetics modeling of cell identity genes, Role of S-nitrosylation in Transdifferentiation, G2040153736, THE ROLE OF A-TO-I RNA EDITING IN ADVANCED PROSTATE CANCER...NEW GRANT, SIGNED 9/12/2019, EFFECTIVE 9/30/2019, DISTRIBUTED 9/16/2019, FAADC 9/16/2019, The inhibitory network between EZH2 and PARP1 in triple-negative breast cancer, G4119534169, G5850682332, NEUROENDOCRINE DIFFERENTIATION AND ENZALUTAMIDE RESISTANCE IN PROSTATE CANCER, THE ROLE OF BMI1-ASSOCIATED LNCRNAS IN ADVANCED PROSTATE CANCER, Reversal of Heart Failure: Role of Vascular Recovery, A novel role for EZH2 in A-to-I RNA editing in prostate cancer, A non-canonical role for EZH2 in rRNA methtlation, Transcription Factor 4 Maintain Endothelial identity to Oppose Heart Failure, Bioinformatics Techniques to Analyze Dynamic Changes of 3D Genome, SPORE in Prostate Cancer
OpenAlex ID: W4391849985